Drug profile · INN
naltrexone
MYSIMBA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
naltrexone (MYSIMBA) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
INN naltrexone
Brand MYSIMBA
Route INTRAMUSCULAR
Formulation FOR SUSPENSION, EXTENDED RELEASE
ATC code A08AA
Originator Teva Pharma GmbH
Frequently asked questions
What is naltrexone?
naltrexone (MYSIMBA) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for naltrexone?
MYSIMBA is a marketed brand name for naltrexone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naltrexone?
naltrexone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.